Luminescent lanthanide complexes for reactive oxygen species biosensing and possible application in Alzheimer's diseases. (19th May 2021)
- Record Type:
- Journal Article
- Title:
- Luminescent lanthanide complexes for reactive oxygen species biosensing and possible application in Alzheimer's diseases. (19th May 2021)
- Main Title:
- Luminescent lanthanide complexes for reactive oxygen species biosensing and possible application in Alzheimer's diseases
- Authors:
- Galaup, Chantal
Picard, Claude
Couderc, François
Gilard, Véronique
Collin, Fabrice - Abstract:
- Abstract : Histopathological hallmarks of Alzheimer's disease (AD) are intracellular neurofibrillary tangles and extracellular formation of senile plaques composed of the aggregated amyloid‐beta peptide along with metal ions (copper, iron or zinc). In addition, oxidative stress is considered as an important factor in the etiology of AD and a multitude of metalloproteins and transporters is affected, leading to metal ion misregulation. Redox‐active metal ions (e.g., copper) can catalyze the production of reactive oxygen species (ROS) in the presence of molecular oxygen and a reductant such as ascorbate. The ROS thus produced, in particular the hydroxyl radical which is the most reactive one, may contribute to oxidative stress conditions. Thus, detecting ROS in vivo or in biological models of AD is of interest for better understanding AD etiology. The use of biocompatible and highly specific and sensitive probes is needed for such a purpose, since ROS are transient species whose steady‐state concentrations are very low. Luminescent lanthanide complexes are sensitive probes that can meet these criteria. The present review focuses on the recent advances in the use of luminescent lanthanide complexes for ROS biosensing. It shows why the use of luminescent lanthanide complexes is of particular interest for selectively detecting ROS ( O 2 · ‐, HO, 1 O2, H2 O2, etc.) in biological samples in the µM‐nM range. It particularly focuses on the most recent strategies and discusses whatAbstract : Histopathological hallmarks of Alzheimer's disease (AD) are intracellular neurofibrillary tangles and extracellular formation of senile plaques composed of the aggregated amyloid‐beta peptide along with metal ions (copper, iron or zinc). In addition, oxidative stress is considered as an important factor in the etiology of AD and a multitude of metalloproteins and transporters is affected, leading to metal ion misregulation. Redox‐active metal ions (e.g., copper) can catalyze the production of reactive oxygen species (ROS) in the presence of molecular oxygen and a reductant such as ascorbate. The ROS thus produced, in particular the hydroxyl radical which is the most reactive one, may contribute to oxidative stress conditions. Thus, detecting ROS in vivo or in biological models of AD is of interest for better understanding AD etiology. The use of biocompatible and highly specific and sensitive probes is needed for such a purpose, since ROS are transient species whose steady‐state concentrations are very low. Luminescent lanthanide complexes are sensitive probes that can meet these criteria. The present review focuses on the recent advances in the use of luminescent lanthanide complexes for ROS biosensing. It shows why the use of luminescent lanthanide complexes is of particular interest for selectively detecting ROS ( O 2 · ‐, HO, 1 O2, H2 O2, etc.) in biological samples in the µM‐nM range. It particularly focuses on the most recent strategies and discusses what could be expected with the use of luminescent lanthanide complexes for better understanding some of the molecular mechanisms underlying the development of Alzheimer's disease. Abstract : The detection of reactive oxygen species (ROS) in vivo or in biological systems is of interest for the better understanding of the development of certain pathologies for which oxidative stress plays an important role. The use of luminescent lanthanide complexes seems to be particularly judicious for such purpose because it allows sensitive and selective detection of ROS. … (more)
- Is Part Of:
- FEBS journal. Volume 289:Number 9(2022)
- Journal:
- FEBS journal
- Issue:
- Volume 289:Number 9(2022)
- Issue Display:
- Volume 289, Issue 9 (2022)
- Year:
- 2022
- Volume:
- 289
- Issue:
- 9
- Issue Sort Value:
- 2022-0289-0009-0000
- Page Start:
- 2516
- Page End:
- 2539
- Publication Date:
- 2021-05-19
- Subjects:
- amyloid‐beta peptide -- biomolecules -- lanthanide -- luminescence -- oxidative stress
Biochemistry -- Periodicals
Molecular biology -- Periodicals
Pathology, Molecular -- Periodicals
572 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01038983-000000000-00000 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=ejb ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=ejb ↗ - DOI:
- 10.1111/febs.15859 ↗
- Languages:
- English
- ISSNs:
- 1742-464X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3901.578500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21320.xml